Support funding for research into new pain relief treatments so patients can recover without addiction risk.

John R. Moolenaar · Michigan · Republican

spending impact 0.58 specificity 0.80 extraction confidence 93%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

I have also backed legislation funding research into new pain relief treatments so patients can safely recover without the risk of addiction.

Moolenaar commits to supporting research funding for safer pain relief alternatives.

Health Care | Congressman John Moolenaar
primary · other · model gpt-5.4-mini

Evidence

legacy_unverified · Source version not recorded · locator unknown

I support funding for states to combat the opioid crisis and I have also backed legislation funding research into new pain relief treatments so patients can safely recover without the risk of addiction.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Moolenaar’s official issues page explicitly restates support for funding pain-relief research and opioid-crisis funding, but it does not show a new concrete delivery action in the last 30 days.

unresolved unknown

Issues | Congressman John Moolenaar
primary · model gpt-5.4-mini · confidence 92%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): unresolved. unknown

The provided evidence only shows Moolenaar stating support for funding opioid-crisis work and research into non-addictive pain relief treatments. It does not identify a specific bill, appropriation, amendment, vote, enacted funding stream, or other concrete action attributable to him that delivered the promised research funding. Because the record is limited to a position statement and lacks outcome evidence, fulfillment cannot be adjudicated as delivered or failed.

provider codex_cli · model gpt-5.5 · confidence 74%